At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
NDRA ENDRA Life Sciences Inc
Post-Mkt 02-10 19:26:58 EST
3.73
-0.07
-1.84%
盘后3.60
-0.13-3.49%
18:26 EST
High3.75
Low3.60
Vol6.63K
Open3.75
D1 Closing3.80
Amplitude3.95%
Mkt Cap4.35M
Tradable Cap4.35M
Total Shares1.17M
T/O24.42K
T/O Rate0.57%
Tradable Shares1.17M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
ENDRA Life Sciences Is Maintained at Buy by Ascendiant Capital
ENDRA Life Sciences Outlines Ongoing Digital Asset Strategy with Plans to Stake HYPE Tokens, Enhance Balance Sheet Diversification, and Explore Further DeFi Opportunities
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.